Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion type Assertion NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_head.
- NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion description "[The most highly upregulated marker, CD62L, was examined further for expression on CD5(+)/CD19(+) CLL cells in vitro and in lymph node and bone marrow biopsies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_provenance.
- NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion evidence source_evidence_literature NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_provenance.
- NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion SIO_000772 23948971 NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_provenance.
- NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion wasDerivedFrom befree-2016 NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_provenance.
- NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_assertion wasGeneratedBy ECO_0000203 NP1102757.RA05Gi8G8CyCKHF6sGfL6VmgSLp2P1nr-KLXKEmgCpeYo130_provenance.